Sign in
  • R&D
  • Clinical
  • Commercial
    • Brand & Marketing
  • Technology
  • Insights
  • Podcast
  • Awards
    • Rising Stars Award 2025 Nominations
    • Winners of LSV Top Industry Leaders Award 2024
    • List of Winners of the Rising Stars Award 2024
  • More
    • Manufacturing
    • Regulatory
    • Editorial
Sign in
Welcome!Log into your account
Forgot your password?
Privacy Policy
Password recovery
Recover your password
Search
LogoLifeNewsLife Science
LogoFashion Trends and Culture
  • R&D
    • Research & Development

      New Data Positions Immutep’s Immunotherapy Combo as First-Line Option for PD-L1-Negative HNSCC

      May 7, 2025
      Research & Development

      BioMed X Launches XBridge Program to Support U.S. Reacsearchers Amid NIH Funding Cuts

      April 8, 2025
      Research & Development

      Taiho spends $400 million with a Swiss partner to “turbocharge” three ADCs to the clinic

      March 20, 2025
      Research & Development

      Élancé Therapeutics Joins the Race to Develop Next-Generation Obesity Therapies

      March 14, 2025
  • Clinical
    • Clinical

      Vertex Presses Pause on CF Study, Reports Major Write-Down

      May 9, 2025
      Clinical

      J&J Gene Therapy Treatment For Vision Loss Fails to Meet Primary Endpoints

      May 7, 2025
      Clinical

      Pfizer’s PD-1 Inhibitor Shows Mixed Results in Bladder Cancer Trial

      April 29, 2025
      Clinical

      Medtronic Highlights Improved Results with Affera PFA Technology

      April 29, 2025
  • Commercial
    • AllBrand & Marketing
      Commercial

      Pathos AI Secures $365 Million in Series D Funding to Accelerate AI-Powered Cancer Drug Development

      May 20, 2025
      Commercial

      Eli Lilly Invests $250 Million to Strengthen Ties with Purdue University

      May 13, 2025
      Commercial

      Eli Lilly Secures Rights to Alchemab’s Early-Stage ALS Drug in $415M Deal

      May 9, 2025
  • Technology
    • Technology

      J&J MedTech presents the first Ottava surgical robot clinical cases

      April 17, 2025
      Commercial

      Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

      October 23, 2024
      Technology

      PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

      September 26, 2024
      Technology

      Elon Musk Announces Neuralink’s Second Brain-Computer Chip Implantation in a Patient

      August 8, 2024
  • Insights
    • Insights

      The now-urgent automation agenda: out-of-control regulatory workloads necessitate AI adoption

      December 1, 2024
      Insights

      Improving life science R&D outcomes with AI

      November 8, 2024
      Insights

      The medical device sector’s surging regulatory burden: how are suppliers coping?

      October 12, 2024
      Insights

      The Future of Gene Therapies: Three Trends

      March 18, 2023
  • Podcast
  • Awards
    • Rising Stars Award 2025 Nominations
    • Winners of LSV Top Industry Leaders Award 2024
    • List of Winners of the Rising Stars Award 2024
  • More
    • Manufacturing
    • Regulatory
    • Editorial
type here...
Facebook
Linkedin
Twitter
Home News Page 2

News

Latest
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

China forces insulin price cuts resulting in pullback for global pharma players

Editorial Team - January 24, 2022

Aussie pharma CSL in talks to buy Swiss firm Vifor Pharma for USD 7B

Sanofi to acquire Origimm Biotechnology in a bid to expand vaccine pipeline

Aduhelm Biogen's Alzheimer’s | drug worth $56K? | Experts $8400 | 2021

Is Biogen’s Alzheimer’s drug worth $56K? Experts say $8400 and raise questions about efficacy

AstraZeneca and FibroGen hit FDA committee's safety data firewall for roxadustat

AstraZeneca and FibroGen hit FDA committee’s safety data firewall for roxadustat

Pharma manufacturers lawsuits against payers and benefit managers preferred drugs are on FTC's radar

Pharma manufacturers lawsuits against payers and benefit managers preferred drugs are...

Editorial Team - July 12, 2021 0
123...26Page 2 of 26

Editor Picks

Six Things to Know in August 2022 Third Week

December 10, 2022

Bayer relying on Kerendia to drive pharma business growth with five kidney indications in sight

August 20, 2021

Aussie pharma CSL in talks to buy Swiss firm Vifor Pharma for USD 7B

January 17, 2022

Must Read

FDA Delays Biohaven’s Approval Decision for Rare Disease Drug Troriluzole

May 20, 2025

Pathos AI Secures $365 Million in Series D Funding to Accelerate AI-Powered Cancer Drug Development

May 20, 2025

Life Sciences Voice Top Five Newsletter

May 20, 2025

Hot Topics

  • Commercial295
  • Clinical292
  • Regulatory242
  • Research & Development97
  • Newsletter54
  • Manufacturing51
  • Technology39
  • News31
Logo

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Contact us: reachout(at)lifescivoice.com

Follow Us

Facebook
Instagram
Linkedin
Twitter

© Copyright - Life Sciences Voice

  • R&D
  • Clinical
  • Commercial
  • Technology
  • Insights
  • Podcast
  • Awards
    • Rising Stars Award 2025 Nominations
    • Winners of LSV Top Industry Leaders Award 2024
    • List of Winners of the Rising Stars Award 2024
  • More
    • Manufacturing
    • Regulatory
    • Editorial